<?xml version="1.0" encoding="UTF-8"?>
<list>
  <sentences>
    <s path="file:/D:/Corpora/oanc/data/written_2/technical/biomed/1471-2091-3-30.anc" start="34029" end="34036" sStart="-1" offset="0" sid="null" wn="2" wnkey="write%2:32:00::" text="CCL conceived of the study, participated in its design and coordination, and participated in &lt;b&gt;writing&lt;/b&gt; the draft." />
    <s path="[OANC]/data/written_2/technical/biomed/1471-2091-3-30.anc" start="31438" end="31443" sStart="null" offset="37" sid="r7.1.use.v.0303" wn="1" wnkey="use%2:34:01::" text="Final images were produced using Adobe Photoshop." />
    <s path="[OANC]/data/written_2/technical/biomed/1471-2091-3-30.anc" start="4909" end="4916" sStart="null" offset="287" sid="r8.suggest.v.0248" wn="3" wnkey="suggest%2:32:02::" text="In addition, using cells expressing wild-type cPLA 2 and cPLA 2 with S505A or S727A mutations, it was found that translocation kinetics and membrane targeting in response to ATP or ionomycin was similar to wild-type cPLA 2 . These data suggest that MEK1 inhibition reduces cPLA 2 catalytic activity and AA release independently of phosphorylation and translocation." />
    <s path="file:/c:/OANC/data/written_2/technical/biomed/1471-2091-3-30.anc" start="20294" end="20299" sStart="null" offset="0" sid="null" wn="5" wnkey="show%2:36:00::" text="The results &lt;b&gt;shown&lt;/b&gt; here demonstrate that inhibition of MEK with U0126 quantitatively inhibits both ERK phosphorylation and AA release in MDCK cells in response to [Ca 2+] i mobilization." />
    <s path="file:/c:/OANC/data/written_2/technical/biomed/1471-2091-3-30.anc" start="20294" end="20299" sStart="null" offset="0" sid="null" wn="4" wnkey="show%2:39:00::" text="The results &lt;b&gt;shown&lt;/b&gt; here demonstrate that inhibition of MEK with U0126 quantitatively inhibits both ERK phosphorylation and AA release in MDCK cells in response to [Ca 2+] i mobilization." />
    <s path="file:/c:/OANC/data/written_2/technical/biomed/1471-2091-3-30.anc" start="20294" end="20299" sStart="null" offset="0" sid="null" wn="2" wnkey="show%2:31:00::" text="The results &lt;b&gt;shown&lt;/b&gt; here demonstrate that inhibition of MEK with U0126 quantitatively inhibits both ERK phosphorylation and AA release in MDCK cells in response to [Ca 2+] i mobilization." />
    <s path="file:/c:/OANC/data/written_2/technical/biomed/1471-2091-3-30.anc" start="20294" end="20299" sStart="null" offset="0" sid="null" wn="4" wnkey="show%2:39:00::" text="The results &lt;b&gt;shown&lt;/b&gt; here demonstrate that inhibition of MEK with U0126 quantitatively inhibits both ERK phosphorylation and AA release in MDCK cells in response to [Ca 2+] i mobilization." />
    <s path="file:/c:/OANC/data/written_2/technical/biomed/1471-2091-3-30.anc" start="20294" end="20299" sStart="null" offset="0" sid="null" wn="5" wnkey="show%2:36:00::" text="The results &lt;b&gt;shown&lt;/b&gt; here demonstrate that inhibition of MEK with U0126 quantitatively inhibits both ERK phosphorylation and AA release in MDCK cells in response to [Ca 2+] i mobilization." />
    <s path="file:/D:/Corpora/oanc/data/written_2/technical/biomed/1471-2091-3-30.anc" start="34060" end="34064" sStart="null" offset="0" sid="null" wn="1" wnkey="read%2:31:00::" text="All authors &lt;b&gt;read&lt;/b&gt; and approved the final manuscript." />
    <s path="file:/D:/Corpora/oanc/data/written_2/technical/biomed/1471-2091-3-30.anc" start="15965" end="15970" sStart="null" offset="0" sid="null" wn="1" wnkey="rapid%5:00:00:fast:01" text="Following stimulation with 100 ?M ATP, there was a &lt;b&gt;rapid&lt;/b&gt; translocation of EYFP-cPLA 2 to Golgi that was unaffected by U0126 (Fig." />
    <s path="file:/D:/Corpora/oanc/data/written_2/technical/biomed/1471-2091-3-30.anc" start="15965" end="15970" sStart="null" offset="0" sid="null" wn="1" wnkey="rapid%5:00:00:fast:01" text="Following stimulation with 100 ?M ATP, there was a &lt;b&gt;rapid&lt;/b&gt; translocation of EYFP-cPLA 2 to Golgi that was unaffected by U0126 (Fig." />
    <s path="file:/D:/Corpora/oanc/data/written_2/technical/biomed/1471-2091-3-30.anc" start="21585" end="21590" sStart="null" offset="0" sid="null" wn="1" wnkey="rapid%5:00:00:fast:01" text="1 cells, without constitutively active ERKs, AA release is delayed after [Ca 2+] i mobilization, and is temporally correlated with ERK activation [ 40 ] , whereas in MDCK cells with constitutively active ERKs, AA release is &lt;b&gt;rapid&lt;/b&gt;, with significant AA release measured 30 s after [Ca 2+] i increase [ 15 ] . This temporal correlation between AA release and ERK activation has also been reported in CHO cells in response to PAF stimulation [ 35 41 ] . These results support the observations made here that ERK activity is required for phospholipid hydrolysis independently of cPLA 2 translocation." />
    <s path="[OANC]/data/written_2/technical/biomed/1471-2091-3-30.anc" start="687" end="697" sStart="null" offset="280" sid="r10.particular.j.0293" wn="3" wnkey="particular%5:00:00:uncommon:00" text="Certain prostaglandins are required for female reproduction and kidney function [ 3 4 5 ] . Because of its important role in controlling levels of arachidonic acid (AA), much attention has been focused on the regulation of cPLA 2 activation, with particular emphasis on the role of its phosphorylation and Ca 2+-mediated translocation [ 6 7 8 ] ." />
    <s path="[OANC]/data/written_2/technical/biomed/1471-2091-3-30.anc" start="367" end="373" sStart="null" offset="324" sid="r9.normal.j.0758" wn="2" wnkey="normal%3:00:02::" text="Cytosolic PLA 2 specifically hydrolyzes sn-2 arachidonate from phospholipid providing the precursors for many different lipid mediators including prostaglandins and leukotrienes [ 1 2 ] . These lipid metabolites play a role in acute inflammatory responses and also regulate normal physiological processes." />
    <s path="[OANC]/data/written_2/technical/biomed/1471-2091-3-30.anc" start="23346" end="23350" sStart="null" offset="254" sid="r10.high.j.0639" wn="1" wnkey="high%3:00:02::" text="In contrast, cPLA 2 S505A is active in vitro and phosphorylation only modestly increases the activity of the enzyme [ 16 17 24 ] . Interestingly, the inhibitory effect of the S505A mutation on AA release is obviated by a high [Ca 2+] i increase." />
    <s path="[OANC]/data/written_2/technical/biomed/1471-2091-3-30.anc" start="21199" end="21203" sStart="null" offset="20" sid="r10.high.j.0258" wn="1" wnkey="high%3:00:02::" text="However, at high density ERKs are less active and can be further activated by phorbol ester (not shown)." />
    <s path="[OANC]/data/written_2/technical/biomed/1471-2091-3-30.anc" start="22202" end="22210" sStart="null" offset="171" sid="r11.function.n.0451" wn="3" wnkey="function%1:04:00::" text="cPLA 2 -mediated AA release must be preceded by translocation of the enzyme to its membrane substrate which is a Ca 2+-dependent process and is a function of the calcium-dependent lipid-binding (C2) domain." />
    <s path="[OANC]/data/written_2/technical/biomed/1471-2091-3-30.anc" start="3009" end="3017" sStart="null" offset="512" sid="r11.function.n.0279" wn="2" wnkey="function%1:07:00::" text="Phosphorylation of Ser 505has been extensively studied because it is readily detected due to a characteristic electrophoretic mobility shift when analyzed by SDS-PAGE [ 13 16 ] . The importance of Ser 505phosphorylation in regulating cPLA 2 has been demonstrated in different cells and in vitro models by using cPLA 2 containing a S505A mutation [ 16 22 ] . However, the mechanism whereby Ser 505phosphorylation regulates cPLA 2 function has been elusive." />
    <s path="[OANC]/data/written_2/technical/biomed/1471-2091-3-30.anc" start="7362" end="7366" sStart="null" offset="136" sid="r9.fold.v.0501" wn="2147483645" wnkey="null" text="This inhibition was independent of the total amount of AA released, since AA release stimulated by 10 ?M IONO was 3-fold greater than release stimulated with 1 ?M IONO or 100 ?M ATP, but the percent inhibition by U0126 was similar." />
    <s path="[OANC]/data/written_2/technical/biomed/1471-2091-3-30.anc" start="6276" end="6280" sStart="null" offset="65" sid="r9.fold.v.0354" wn="" wnkey="null" text="2 , it is necessary to over-express the enzyme several fold as previously reported [ 16 ] . Cytosolic PLA 2 has been shown to mediate Ca 2+-induced AA release in MDCK cells treated with ATP and IONO in experiments using the group IV cPLA 2 ?-specific inhibitor pyrrolidine-1 [ 27 ] . To measure cPLA 2 mediated AA release, EGFP-cPLA 2 -transfected MDCK cells labeled with [ 3H]-AA were incubated with 0.3, 1 or 10 ?M U0126 for 15 min prior to stimulation with 100 ?M ATP, 1 ?M IONO, or 10 ?M IONO." />
    <s path="file:/D:/Corpora/oanc/data/written_2/technical/biomed/1471-2091-3-30.anc" start="29047" end="29052" sStart="null" offset="0" sid="null" wn="1" wnkey="add%2:30:00::" text="Laemmli electrophoresis sample buffer (5?) was &lt;b&gt;added&lt;/b&gt; to the lysates, and SDS-polyacrylamide gel electrophoresis and immunoblotting were performed using 35 ?g lysate protein, phospho-specific antibodies for ERK and p38, and rabbit polyclonal antibody for cPLA 2 [ 21 ] ." />
    <s path="[OANC]/data/written_2/technical/biomed/1471-2091-3-30.anc" start="11526" end="11533" sStart="null" offset="35" sid="r11.absence.n.0978" wn="1" wnkey="absence%1:26:00::" text="ATP and ionomycin treatment in the absence of anisomycin only weakly increased p38 phosphorylation." />
    <s path="[OANC]/data/written_2/technical/biomed/1471-2091-3-30.anc" start="15886" end="15893" sStart="null" offset="366" sid="r11.absence.n.0333" wn="1" wnkey="absence%1:26:00::" text="To investigate this possibility, cells were transfected with a wild-type cPLA 2 fused to EYFP (EYFP-cPLA 2 ) and the distribution of EYFP-cPLA 2 was imaged in response to [Ca 2+] i transients elicited by ATP and sustained [Ca 2+] i elevations elicited by IONO, in the presence and absence of U0126." />
  </sentences>
</list>